Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans.

Yu-Luan ChenHironobu TsukadaSnezana MilanovicLei ShiYan LiYongcai MaoKenneth S KoblanGerald R Galluppi

Published in: Neurology and therapy (2023)

for ulotaront were well within typical bioequivalence criteria of 80-125% for both the BE and FE studies, thereby confirming the bioequivalence of the two dosage forms and no significant food effect.

Keyphrases

human health
risk assessment
case control